SP Funds S&P 500 Sharia Industry Exclusions ETF vs Stryker Corporation — how do they compare? SP Funds S&P 500 Sharia Industry Exclusions ETF trades at $57.02, while Stryker Corporation trades at $319.04 (market cap $122.35B). The key difference: Stryker Corporation pays a 1% dividend while SP Funds S&P 500 Sharia Industry Exclusions ETF pays none, and SP Funds S&P 500 Sharia Industry Exclusions ETF is trading nearer its 52-week high, Stryker Corporation nearer its low. Which is the better fit depends on your goals.
| SPUS | SYK | |
|---|---|---|
Sector | Broad Market / Factor | Technology |
52-Week High | $59.51 | $403.53 |
52-Week Low | $45.32 | $282.58 |
Market Cap | — | $122.35B |
Enterprise Value | — | $134.10B |
Dividend Yield | — | 1% |
Signals from Pluang's Aura AI — not financial advice
SPUS trades at $57.07, up 1.1% today, with a bearish technical signal from moving averages. The stock exhibits a consistent dividend payout pattern, with recent quarterly dividends of $0.03. Support and resistance levels suggest near-term price consolidation. Financial ratios are not available in the provided data.
The outlook for SPUS is mixed, with technical weakness offset by dividend stability. Risks include broader market volatility and reliance on dividend strategies. Upside potential hinges on sustained profitability and positive earnings momentum.
No Aura AI signal available yet.
Trailing returns across standard periods
SPUS tracks a market-cap weighted index of S&P 500 stocks that adhere to Sharia law. It screens out companies involved in non-compliant business activities such as alcohol, tobacco, gambling, and conventional finance, as well as excluding sectors like Aerospace & Defense, and Data Processing. By focusing on low-leverage stocks, SPUS provides investors with a value-conscious, ethically-aligned exposure to a diversified portfolio of large-cap U.S. equities.
Read more on SPUS →Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →